Kamalesh Kumar Bala, M.D.

78% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

197 Medicare Part D claims for 72 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 30% of claims.

Most prescribed

1. Eliquis29 claims
2. Anastrozole19 claims
3. Letrozole13 claims
4. Gabapentin12 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 72.7 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $643.34

2 payments; by number, the most common kind was consulting fee; the largest payer was Daiichi Sankyo Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

2 hospitals and group practices

1. Benefis Hospitals IncGreat Falls, MT · Acute Care Hospitals2 of 5 stars
2. Cumberland County Hospital System IncFayetteville, NC

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.